Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant mitotane after radical resection for adrenocortical carcinoma
2007-007262-38Phase 3Active
- Sponsor
- San Luigi Gonzaga Hospital
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of mitotane in adrenal cancer (ACC) (2 arms), sponsored by San Luigi Gonzaga Hospital. Primary endpoints: Disease-free survival, Local or distant recurrence and 1 more. Started Mar 2008; status: active.
02
Drugs
mitotane
03
Conditions
adrenal cancer (ACC)
Beyond the preview
Go deeper on 2007-007262-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007262-38.